The discovery of Checkpoint Inhibitors was hailed as a possible cure for cancer and for some, like ex-President Jimmy Carter, they have been quite successful. New research at the Technical University of Munich found that inactivation of a protein receptor led to decreased responsiveness to Checkpoint Inhibitors...
RIG-I is a receptor protein that is known to play a role in the body's defense against viruses. Heidegger and a team headed by his colleague Dr. Hendrik Poeck have now discovered that RIG-I also plays a key role in cancer control.
short version:
sciencedaily.com/releases/2...
Article:
immunology.sciencemag.org/c...
Fortunately, a drug already exists that activates RIG-I, and it is already undergoing initial tests in clinical trials with humans...
The Science is Coming....
Don Pescado